Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03726242Completed
Trial of levcromakalim in pain (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Occurrence and change of pain from baseline and Occurrence and change of Itching from baseline. Started Nov 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03726242.